Kodiak Sciences (KOD) Treasury Shares (2017 - 2025)
Kodiak Sciences (KOD) posted Treasury Shares of $120820.0 for Q4 2025, down 12.73% on a QoQ basis from $138451.0 in Q3 2025, and little changed year-over-year from $120820.0 in Q4 2024.
Kodiak Sciences (KOD) Treasury Shares (2017 - 2025) Analysis & Trends
Kodiak Sciences' Treasury Shares history runs 9 years deep, the most recent figure standing at $120820.0 for Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $120820.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $120820.0 (changed 0.0% YoY) and the FY2025 annual result came in at $120820.0, changed 0.0% from the prior year.
- Treasury Shares was $120820.0 for Q4 2025 at Kodiak Sciences, down from $138451.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $412287.0 in Q3 2021 and bottomed at $117892.0 in Q2 2025.
- A 5-year average of $227141.7 and a median of $199622.0 in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2021 — Treasury Shares jumped 138.8% — and 2024, when it plunged 46.0%.
- Kodiak Sciences' Treasury Shares stood at $363930.0 in 2021, then dropped by 22.92% to $280522.0 in 2022, then plunged by 41.25% to $164817.0 in 2023, then retreated by 26.69% to $120820.0 in 2024, then changed by 0.0% to $120820.0 in 2025.
- Business Quant data shows KOD's Treasury Shares at $120820.0 in Q4 2025, $138451.0 in Q3 2025, and $117892.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 120,820.00 |
| Dec 31, 2025 | 120,820.00 |
| Sep 30, 2025 | 138,451.00 |
| Sep 30, 2025 | 138,451.00 |
| Jun 30, 2025 | 117,892.00 |
| Jun 30, 2025 | 117,892.00 |
| Mar 31, 2025 | 133,253.00 |
| Mar 31, 2025 | 133,253.00 |
| Dec 31, 2024 | 120,820.00 |
| Dec 31, 2024 | 120,820.00 |
| Sep 30, 2024 | 122,349.00 |
| Sep 30, 2024 | 122,349.00 |
| Jun 30, 2024 | 127,521.00 |
| Jun 30, 2024 | 127,521.00 |
| Mar 31, 2024 | 151,716.00 |
| Mar 31, 2024 | 151,716.00 |
| Dec 31, 2023 | 164,817.00 |
| Dec 31, 2023 | 164,817.00 |
| Sep 30, 2023 | 186,267.00 |
| Sep 30, 2023 | 186,267.00 |